Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors

Details for Australian Patent Application No. 2004209319 (hide)

Owner Aventis Pharma S.A.

Inventors Nemecek, Conception; Bond, Daniel; Harlow, Greg; Bouchard, Herve; Mauger, Jacques; Malleron, Jean-Luc; Palermo, Mark; Al-Obeidi, Fahad; Faitg, Thomas; Strobel, Hartmut; Ruf, Sven; Ritter, Kurt; El-Ahmad, Youssef; Lesuisse, Dominique; Benard, Didier; Patek, Marcel; Nair, Anil; Hittinger, Augustin

Agent Watermark

Pub. Number AU-A-2004209319

PCT Pub. Number WO2004/070050

Priority 03/01098 31.01.03 FR

Filing date 28 January 2004

Wipo publication date 19 August 2004

International Classifications

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/070050 Priority application(s): WO2004/070050

26 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004209334-Emanator blister

2004209310-Method for making a fiber glass and cellulose mat in cationic medium